{"id":"W2895587415","doi":"10.3389/fphar.2018.01093","title":"The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond","year":2018,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Fondation Leducq","keywords":"Pioglitazone; Thiazolidinedione; Medicine; Rosiglitazone; Adverse effect; Pharmacology; Insulin resistance; Type 2 diabetes; Glucose homeostasis; Clinical trial; Bioinformatics; Diabetes mellitus; Internal medicine; Endocrinology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005290724,0.0005088477,0.0008519044,0.001499958,0.0003152667,0.001197793,0.0006368315,0.001117746,0.005124269],"category_scores_gemma":[0.0006593723,0.0001757613,0.0003633607,0.001482974,0.0006774766,0.001959034,0.0007394869,0.002633348,0.003113416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000615983,"about_ca_system_score_gemma":0.001283239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006892206,"about_ca_topic_score_gemma":0.001452956,"domain_scores_codex":[0.9998242,0.00003018143,0.00002334007,0.00003005462,0.00007294048,0.00001923186],"domain_scores_gemma":[0.999719,0.0001185854,0.00003388567,0.00001230857,0.00007641134,0.00003993206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000953543,0.00006499988,0.0001189162,0.009906432,0.00003988641,0.0002724706,0.00009875981,0.000176028,0.002154693,0.01310957,0.05964167,0.9143213],"study_design_scores_gemma":[0.000009605587,0.00005131427,0.0001474876,0.001216981,0.00001795484,0.0004403662,0.00003871916,0.00002143862,0.000198462,0.002492748,0.9953588,0.000006202148],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001267003,0.9950439,0.0001842153,0.001517832,0.0007538159,0.000004735155,0.00001944853,0.00001366689,0.0023357],"genre_scores_gemma":[0.0009133203,0.9956661,0.0002398929,0.0008844727,0.0004356453,0.000005353844,0.00002491751,0.000003022684,0.001827219],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005124269,"threshold_uncertainty_score":0.01714242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01501392434510712,"score_gpt":0.3245149973397092,"score_spread":0.3095010729946021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}